References
Key articles
Gibbs S, Harvey I, Sterling J, et al. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325:461.Full text Abstract
Kwok CS, Gibbs S, Bennett C, et al. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;(9):CD001781.Full text Abstract
Dall'oglio F, D'Amico V, Nasca MR, et al. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13:73-96. Abstract
Reference articles
1. Tyring S, Yen Moore A, Lupi O. Mucocutaneous manifestations of viral diseases: an illustrated guide to diagnosis and management. 2nd ed. Boca Raton (FL): CRC Press; 2010.Full text
3. Lynch MD, Cliffe J, Morris-Jones R. Management of cutaneous viral warts. BMJ. 2014 May 27;348:g3339.Full text Abstract
4. Ramos-e-Silva M, Ribeiro de Castro MC. Mycobacterial infections. In: Bolgnia JL, Jorizzo JL, and Rapini RP, eds. Dermatology. 2nd ed. Philadelphia, PA: Elsevier; 2008:1115-1116.
5. Sterling JC, Gibbs S, Haque Hussain SS, et al. British Association of Dermatologists' guidelines for the management of cutaneous warts 2014. Br J Dermatol. 2014;171:696-712.Full text Abstract
6. Gibbs S, Harvey I, Sterling J, et al. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325:461.Full text Abstract
7. Keogh-Brown MR, Fordham RJ, Thomas KS, et al. To freeze or not to freeze: a cost-effectiveness analysis of wart treatment. Br J Dermatol. 2007;156:687-692. Abstract
8. Focht DR 3rd, Spicer C, Fairchok MP. The efficacy of duct tape vs cryotherapy in the treatment of verruca vulgaris (the common wart). Arch Pediatr Adolesc Med. 2002;156:971-974.Full text Abstract
9. Thomas KS, Keogh-Brown MR, Chalmers JR, et al. Effectiveness and cost-effectiveness of salicylic acid and cryotherapy for cutaneous warts. An economic decision model. Health Technol Assess. 2006;10:iii;ix-87.Full text Abstract
10. Kwok CS, Gibbs S, Bennett C, et al. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2012;(9):CD001781.Full text Abstract
11. Cockayne S, Hewitt C, Hicks K, et al; EVerT Team. Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): a randomised controlled trial. BMJ. 2011;342:d3271. Abstract
12. Kwok CS, Holland R, Gibbs S. Efficacy of topical treatments for cutaneous warts: a meta-analysis and pooled analysis of randomized controlled trials. Br J Dermatol. 2011;165:233-246. Abstract
13. Bruggink SC, Gussekloo J, Berger MY, et al. Cryotherapy with liquid nitrogen versus topical salicylic acid application for cutaneous warts in primary care: randomized controlled trial. CMAJ. 2010;182:1624-1630.Full text Abstract
14. Wenner R, Askari SK, Cham PM, et al. Duct tape for the treatment of common warts in adults: a double-blind randomized controlled trial. Arch Dermatol. 2007;143:309-313.Full text Abstract
15. [No authors listed.] Warts: frequent spontaneous clearance. Prescrire Int. 2012;21:131. Abstract
16. Dall'oglio F, D'Amico V, Nasca MR, et al. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13:73-96. Abstract
17. Ebrahimi S, Dabiri N, Jamshidnejad E, et al. Efficacy of 10% silver nitrate solution in the treatment of common warts: a placebo-controlled, randomized, clinical trial. Int J Dermatol. 2007;46:215-217. Abstract
18. Horn TD, Johnson SM, Helm RM, et al. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. 2005;141:589-594.Full text Abstract
19. Signore RJ. Candida albicans intralesional injection immunotherapy of warts. Cutis. 2002;70:185-192. Abstract
20. Cruz-Pérez DM, Padilla-Desgarennes MC, Alonzo-Romero-Pareyón L, et al. Candidin treatment of patients with resistant warts [in Spanish]. Dermatol Rev Mex. 2011;55:9-16.
21. Kim KH, Horn TD, Pharis J, et al. Phase 1 clinical trial of intralesional injection of Candida antigen for the treatment of warts. Arch Dermatol. 2010;146:1431-1433.Full text Abstract
22. Muzio G, Massone C, Rebora A. Treatment of non-genital warts with topical imiquimod 5% cream. Eur J Dermatol. 2002;12:347-349. Abstract
23. Harwood CA, Perrett CM, Brown VL, et al. Imiquimod cream 5% for recalcitrant cutaneous warts in immunosuppressed individuals. Br J Dermatol. 2005;152:122-129. Abstract
24. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Human papillomavirus disease. Jul 2024 [internet publication].Full text
25. Katz RA. Isotretinoin treatment of recalcitrant warts in an immunosuppressed man. Arch Dermatol. 1986;122:19-20. Abstract
26. Choi YL, Lee KJ, Kim WS, et al. Treatment of extensive and recalcitrant viral warts with acitretin. Int J Dermatol. 2006;45:480-482. Abstract
27. Ormerod AD, Campalani E, Goodfield MJ; BAD Clinical Standards Unit. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010;162:952-963.Full text Abstract
28. Berth-Jones J, Bourke J, Eglitis H, et al. Value of a second freeze-thaw cycle in cryotherapy of common warts. Br J Dermatol. 1994;131:883-886. Abstract
29. Omi T, Numano K. The role of the CO2 laser and fractional CO2 laser in dermatology. Laser Ther. 2014 Mar 27;23(1):49-60.Full text Abstract
30. Kenton-Smith J, Tan ST. Pulsed dye laser therapy for viral warts. Br J Plast Surg. 1999;52:554-558. Abstract
31. Serour F, Somekh E. Successful treatment of recalcitrant warts in pediatric patients with carbon dioxide laser. Eur J Pediatr Surg. 2003;13:219-223. Abstract
32. Logan RA, Zachary CB. Outcome of carbon dioxide laser therapy for persistent cutaneous viral warts. Br J Dermatol. 1989;121:99-105. Abstract
33. Nickles MA, Sergeyenko A, Bain M. Treatment of warts with topical cidofovir in a pediatric patient. Dermatol Online J. 2019 May 15;25(5):13030/qt5sq5b24g.Full text Abstract
34. Moed L, Shwayder TA, Chang MW. Cantharidin revisited: a blistering defense of an ancient medicine. Arch Dermatol. 2001 Oct;137(10):1357-60.Full text Abstract
35. ClinicalTrials.gov. Cantharidin and Occlusion in Verruca Epithelium (COVE-1). NCT03487549. July 2019 [internet publication].Full text
36. Venugopal SS, Murrell DF. Recalcitrant cutaneous warts treated with recombinant quadrivalent human papillomavirus vaccine (types 6, 11, 16, and 18) in a developmentally delayed, 31-year-old white man. Arch Dermatol. 2010 May;146(5):475-7.Full text Abstract
37. Ferguson SB, Gallo ES. Nonavalent human papillomavirus vaccination as a treatment for warts in an immunosuppressed adult. JAAD Case Rep. 2017 Jul 26;3(4):367-369.Full text Abstract
38. Bar-Ilan E, Bar J, Baniel A, et al. Intralesional human papillomavirus vaccine for the treatment of recalcitrant cutaneous warts. J Dermatol. 2023 Jul 27 [Epub ahead of print].Full text Abstract
39. Shen S, Feng J, Song X, et al. Efficacy of photodynamic therapy for warts induced by human papilloma virus infection: A systematic review and meta-analysis. Photodiagnosis Photodyn Ther. 2022 Sep;39:102913. Abstract
40. Wong TH, Morton CA, Collier N, et al. British Association of Dermatologists and British Photodermatology Group guidelines for topical photodynamic therapy 2018. Br J Dermatol. 2019 Apr;180(4):730-9.Full text Abstract
41. Yu YE, Kuohung V, Gilchrest BA, et al. Photodynamic therapy for treatment of hand warts. Dermatol Surg. 2012;38:818-820. Abstract
42. Smith SR, Tyring SK, Grande KK, et al. Hydrogen peroxide topical solution, 45% for common warts: phase 2 efficacy and safety trial results. J Drugs Dermatol. 2020 Oct 1;19(10):969-76. Abstract
43. National Institutes of Health. US National Library of Medicine. ClinicalTrials.gov. A study of A-101 topical solution for the treatment of common warts. October 2019 [internet publication]Full text
44. Chauhan PS, Mahajan VK, Mehta KS, et al. The Efficacy and safety of intralesional immunotherapy with measles, mumps, rubella virus vaccine for the treatment of common warts in adults. Indian Dermatol Online J. 2019 Jan-Feb;10(1):19-26.Full text Abstract
45. Rezai MS, Ghasempouri H, Asqary Marzidareh O, et al. Intralesional injection of the measles-mumps-rubella vaccine into resistant palmoplantar warts: a randomized controlled trial. Iran J Med Sci. 2019 Jan;44(1):10-17.Full text Abstract
46. Amirnia M, Khodaeiani E, Fouladi DF, et al. Intralesional immunotherapy with tuberculin purified protein derivative (PPD) in recalcitrant wart: A randomized, placebo-controlled, double-blind clinical trial including an extra group of candidates for cryotherapy. J Dermatolog Treat. 2016;27(2):173-8. Abstract
47. Shaheen MA, Salem SA, Fouad DA, et al. Intralesional tuberculin (PPD) versus measles, mumps, rubella (MMR) vaccine in treatment of multiple warts: a comparative clinical and immunological study. Dermatol Ther. 2015 Jul-Aug;28(4):194-200. Abstract
48. López-García DR, Gómez-Flores M, Arce-Mendoza AY, et al. Oral zinc sulfate for unresponsive cutaneous viral warts: too good to be true? A double-blind, randomized, placebo-controlled trial. Clin Exp Dermatol. 2009;34:e984-e985. Abstract
49. Simonart T, de Maertelaer V. Systemic treatments for cutaneous warts: a systematic review. J Dermatolog Treat. 2012;23:72-77. Abstract
50. El-Komy MHM, Shamma SG, Bedair NI. The efficacy and safety of intralesional candida vaccine versus topical diphencyproprobenone in immunotherapy of verruca vulgaris: A randomized comparative study. Arch Dermatol Res. 2023 Apr;315(3):583-91.Full text Abstract
51. Pope M, Kyriakides K, Hoffman C. Treatment of warts in pediatrics: a review. J Fam Med Dis Prev. 2020;6(4):132.Full text
52. National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Opportunistic Infections in Children with and Exposed to HIV. Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV. 2024 [internet publication].Full text
53. James WD, Berger T, Elston D. Andrews' diseases of the skin: clinical dermatology. 10th ed. New York, NY: W.B. Saunders; 2006.
54. Chahoud J, Semaan A, Chen Y, et al. Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysis. JAMA Dermatol. 2016 Dec 1;152(12):1354-1364.Full text Abstract
55. Wang J, Aldabagh B, Yu J, et al. Role of human papillomavirus in cutaneous squamous cell carcinoma: a meta-analysis. J Am Acad Dermatol. 2014 Apr;70(4):621-629.Full text Abstract
Use of this content is subject to our disclaimer